Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000711220 | SCV000564884 | uncertain significance | not provided | 2018-03-20 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the CLCN1 gene. The F494L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The F494L variant is observed in 37/10402 (0.4%) alleles from individuals of African background, in the ExAC dataset (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The F494L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, a missense variant at the same residue (F494S) and in nearby residues (A493E/V, R496S, G499R) have been reported in the Human Gene Mutation Database in association with CLCN1-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
| Labcorp Genetics |
RCV001088318 | SCV000759749 | likely benign | Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form | 2024-01-29 | criteria provided, single submitter | clinical testing | |
| Athena Diagnostics | RCV000711220 | SCV000841552 | uncertain significance | not provided | 2021-02-22 | criteria provided, single submitter | clinical testing |